GlycoMimetics, Inc. Reports First Quarter 2014 Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GlycoMimetics, Inc. (NASDAQ: GLYC) today reported financial results for the first quarter ended March 31, 2014. As of March 31, 2014, GlycoMimetics had cash and cash equivalents of $57.0 million, which reflects the company’s January 2014 initial public offering (IPO) in which it sold 8,050,000 shares of its common stock at $8.00 per share, including the underwriters’ exercise in full of their option to purchase 1,050,000 additional shares of common stock.

Help employers find you! Check out all the jobs and post your resume.

Back to news